Delox
Cascais
About Delox
Delox is a spin-off of the Faculty of Sciences of the University of Lisbon, whose goals consist in the design, development, and production of a vast portfolio of automatic bio-decontamination robots. Delox developed DeloxHP, a solid formulation that safely stores and easily releases highly concentrated hydrogen peroxide vapor, which enables the development of simple, compact, cost-effective, and easy to set up bio-decontamination devices such as the Delox Box, Delox's ready-to-market solution. DeloxHP cartridges simplify and ensure the safe and convenient handling and transportation of hydrogen peroxide. Delox's target applications are laboratory equipment and environmental test chambers bio-decontamination, sterilization of medical devices, and room bio-decontamination in hospitals, pharma, and food industry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Seed (Feb 2024)
- Website: delox-global.com
- Phone: +351-217-500-492
Industries & Categories
Biotechnology, Health Care, Hospital
Social Profiles
Canonical: https://fsome.com/organization/delox-91130 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.